Gall Matthew - Insider Non-Derivative Transactions at iTeos Therapeutics, Inc. (ITOS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 29, 2025, Gall Matthew's relationship to iTeos Therapeutics, Inc. (ITOS) is Officer (Chief Financial Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ITOS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gall Matthew - Insider Non-Derivative Transactions of ITOS Common Stock

Gall Matthew - Insider Non-Derivative Transactions at ITOS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 30, 2025	U -- (Common Stock)	89429	0	0
Mar 8, 2025	Acquisition -- (Common Stock)	24000	0	89429
Nov 20, 2024	P -- (Common Stock)	5000	7.73	65429
Dec 6, 2023	Acquisition -- (Common Stock)	41000	0	60429
Oct 13, 2023	P -- (Common Stock)	5000	8.37	19429